NM_002839.4:c.-368+13783G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002839.4(PTPRD):c.-368+13783G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 151,982 control chromosomes in the GnomAD database, including 6,298 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.19   (  6298   hom.,  cov: 33) 
Consequence
 PTPRD
NM_002839.4 intron
NM_002839.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.377  
Publications
7 publications found 
Genes affected
 PTPRD  (HGNC:9668):  (protein tyrosine phosphatase receptor type D) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular region, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this protein is composed of three Ig-like and eight fibronectin type III-like domains. Studies of the similar genes in chicken and fly suggest the role of this PTP is in promoting neurite growth, and regulating neurons axon guidance. Multiple alternatively spliced transcript variants of this gene have been reported. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jan 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.497  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.191  AC: 28955AN: 151864Hom.:  6272  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
28955
AN: 
151864
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.191  AC: 29042AN: 151982Hom.:  6298  Cov.: 33 AF XY:  0.194  AC XY: 14442AN XY: 74278 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
29042
AN: 
151982
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
14442
AN XY: 
74278
show subpopulations 
African (AFR) 
 AF: 
AC: 
20836
AN: 
41438
American (AMR) 
 AF: 
AC: 
3820
AN: 
15270
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
55
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1433
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
786
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
895
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
9
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
901
AN: 
67938
Other (OTH) 
 AF: 
AC: 
307
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 858 
 1716 
 2574 
 3432 
 4290 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 254 
 508 
 762 
 1016 
 1270 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1048
AN: 
3474
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.